Omesdafexor is a FXR agonist. Omesdafexor can be used in the research of liver disease or a metabolic inflammation-mediated disease.
References:
[1]. https://cdn.who.int/media/docs/default-source/international-nonproprietary-names-(inn)/pl127.pdf sfvrsn=8544ca1e_3&download=true
[2]. Song, Kenneth, et al. Farnesoid X receptor agonists for the treatment of a liver disease or a metabolic inflammation-mediated disease or disorder. Patent WO2020061114.
















